The results obtained from HFD + low-dose STZ-induced diabetic mice and L6 cells showed that WS-PE exerted antidiabetic effects via the activation of Akt/GLUT4 and Akt/GSK3β and further improvement of hyperglycemia, IR, and dyslipidemia. Here, AKT1 is linked to metabolic syndrome.